Daxor corporation

Medical/Dental-Instruments

DXR


Empire State Building
New York , NY 10118

Executive/
Director

Price

  • Last Close
  • $ 9.49
    $ +1.96 26.03 %
    Aug 29, 2024
  • 52-Week High/Low
  • $10.04 - $7.2
  • YTD
  • -1%

  • Trading Volume
  • 17
  • Market Cap Full
  • $ 39.8M
  • Shares Outstanding
  • 4.2M
    Mar 22, 2012
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -18.5% 5.6% -10.2% 111% 37.3% -5% -3.2% -3.5% 18.9% -11.9%
Q2 20.4% 0.9% -16.2% -21.4% -29.5% 4% -12.4% 23.9% -11.3% 1.4%
Q3 26.3% -2.8% -17.7% -24.5% 19.5% 8% 10.2% 0.4% -7.4% -
Q4 -11.6% 5% -11.3% 51.6% -5% -20.6% -5.6% -30.3% 1.8% -
J F M A M J J A S O N D
2024 -13.6% -12.6% 16.6% 1.4% - - - - - - - -
2023 -6.8% -3.7% 32.4% 0.2% -11.5% - 0.2% -1.1% -6.5% -14.4% 0.5% 23.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    3%9%9%-44%81%11%37%-12%-16%4%-1%

Earnings

2015 2016 2017 2018 2019 2021 2022 2023
Q1 - - - - - - - -
Q2 - - - - - - - -
Q3 - - - - - - - -
Q4 - - - - - - - -
A 0 0 0 0 0 0 0 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Mar
Jun
Sep
Dec
Annual

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -
Equity multiplier - - - - -